Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Supaglutide

A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients(SUPER-1)

Shanghai Yinnuo Pharmaceutical Technology Co. · Phase 2/3 · Completed · Enrollment 547

NCT04994288

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Supaglutide RP3D high dosen/rn/rn/rn/rn/r
supaglutide RD3D Low dosen/rn/rn/rn/rn/r
placebon/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.